The Claim
The THP-1 human monocyte cell line replicates the inflammatory profile of monocytes from women with preeclampsia, including elevated expression of NLRP1/NLRP3 and TLR4/NF-κB, and is therefore a valid in vitro model for studying preeclampsia-related inflammation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Scientists found that a lab-grown type of immune cell (called THP-1) acts like the immune cells from pregnant women with preeclampsia — it shows the same signs of inflammation. This makes it a useful tool for studying the condition without using human patients.
See the scientific wording
THP-1 human monocyte cell line replicates the inflammatory profile of monocytes from women with preeclampsia, including elevated NLRP1/NLRP3 and TLR4/NF-κB expression, making it a valid in vitro model for studying preeclampsia-related inflammation.
What the research says
1 studyScientists found that immune cells from women with preeclampsia show a specific inflammation pattern, and lab-grown THP-1 cells behave the same way when triggered—so THP-1 cells are a good stand-in for studying this condition in the lab.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.